Abstract
An anorexigen, aminorex fumarate, has been considered to be a cause of primary pulmonary hypertension in Switzerland, West Germany, and Austria. Daily oral doses of aminorex were given to two patas monkeys for 347 days without producing any elevation of pulmonary arterial blood pressure. A subsequent pathological study revealed no evidence of hypertensive pulmonary vascular disease.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
